PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg £50
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg £126
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  6. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  7. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  8. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  9. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  10. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  11. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  12. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  13. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  14. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  15. Guo R, et al. 2022. Cells. 12: . PubMed
  16. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  17. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  18. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  19. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  20. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  21. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  22. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  23. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  24. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  25. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  26. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  27. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  28. Boroumand P, et al. 2022. Elife. 11:. PubMed
  29. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  30. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  31. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  32. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  33. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  34. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  35. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  36. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  37. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  38. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  39. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  40. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  41. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  42. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  43. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  44. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  45. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  46. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  47. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  48. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  49. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  50. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  51. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  52. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  53. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  54. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  55. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  56. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  57. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  58. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  59. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  60. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  61. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  62. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  63. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  64. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  65. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  66. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  67. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  74. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  75. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  76. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  77. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  78. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  79. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  80. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  81. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  82. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  83. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  84. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  85. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  86. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  87. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  88. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  89. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  90. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  91. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  92. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  93. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  94. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  95. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  96. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  97. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  98. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  99. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  100. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  101. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  102. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  103. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  104. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  105. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  106. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  107. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  108. Vorselen D, et al. 2021. Elife. 10:. PubMed
  109. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  110. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  111. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  112. De Simone G, et al. 2021. Immunity. :. PubMed
  113. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  114. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  115. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  116. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  117. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  118. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  119. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  120. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  121. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  122. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  123. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  124. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  125. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  126. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  127. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  128. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  129. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  130. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  131. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  132. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  133. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  134. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  135. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  136. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  137. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  138. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  139. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  140. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  141. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  142. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  143. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  144. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  145. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  146. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  147. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  148. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  149. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  150. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  151. Gu H, et al. 2021. Elife. 10:. PubMed
  152. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  153. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  154. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  155. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  156. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  157. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  158. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  159. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  160. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  161. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  162. Bussey KA, et al. 2019. J Virol. 93. PubMed
  163. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  164. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  165. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  166. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  167. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  168. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  169. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  170. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  171. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  172. Jones GS, et al. 2020. mSphere. 5:. PubMed
  173. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  174. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  175. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  176. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  177. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  178. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  179. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  180. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  181. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  182. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  183. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  184. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  185. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  186. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  187. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  188. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  189. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  190. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  191. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  192. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV™ 395 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account